Zephyrnet Logo

Tag: FDA guidance

Overview of the New FDA Guidance on Cybersecurity

“Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions | FDA” is a new document produced by the FDA that provides...

Top News

FDA Draft Guidance on Third-Party Review: 3P510k Eligibility Factors | United States

The article highlights the key points associated with factors to be considered when determining the eligibility of a medical device type for a third-party...

FDA Draft Guidance on Real-World Evidence: Considerations for Collection and Analysis | United States

The  article highlights the aspects related to the key considerations for methodologies used in the context of the collection and analysis of real-world evidence. ...

FDA Draft Guidance on Translation of GLP Study Reports: Overview | United States

The article provides a brief overview of the approach to be followed for the reports related to studies and reports associated with it. ...

FDA Draft Guidance on Third Party Review Program: Documentation and Reporting | United States

The new article describes in detail the approach to be applied concerning documenting the review process, its completion, and reporting. Table...

FDA Guidance on Notifying on Discontinuance or Interruption: Conditions | FDA

This article highlights the aspects related to the approach to be applied when determining whether a notification is required. Table of...

FDA Guidance on Discontinuance or Interruption Notification: Overview | United States

The article highlights the key points related to notification requirements medical device manufacturers should follow with respect to possible discontinuance or interruption in the...

FDA Guidance on Assessing the Credibility of Computational Modeling and Simulation: Factors, Goals, and Adequacy Assessment | FDA

The article describes in detail the approach to be applied for credibility factors and credibility goals to be considered by the parties responsible for...

FDA Guidance on Assessing the Credibility of Computational Modeling and Simulation: Introduction | RegDesk

The article provides a general overview of the guidance document issued by the US authority and highlights the key points related to the existing...

FDA eSTAR v5.0 – What’s new?

This blog provides a deep dive into the newest version of the FDA eSTAR, version 5.0, released on December 6, 2023. Why did the FDA...

FDA Guidance on General Considerations for Animal Studies: Specific Aspects | RegDesk

The new article highlights the aspects related to the way animal studies should be planned and conducted, including the facility selection, as well as...

FDA Guidance on CFG Requests: Introduction | RegDesk

The new article provides an overview of the new guidance document dedicated to the processes and procedures associated with the review of certain regulatory...

FDA Guidance on Selecting Predicates for 510(k): Specific Aspects | RegDesk

The new article highlights the key points related to the specific aspects of selecting proper predicates to demonstrate compliance with the applicable regulatory requirements...

Latest Intelligence

spot_img
spot_img

Chat with us

Hi there! How can I help you?